RP-56976 |
TAXOTERE |
DOCETAXEL, ANHYDROUS |
N-DEBENZOYL-N-(TERT-BUTOXYCARBONYL)-10-DEACETYLTAXOL |
TXL |
DOCETAXEL |
DOCECAD® |
N-DEBENZOYL-N-(TERT-BUTOXYCARBONYL)-10-DEACETYLPACLITAXEL |
EMDOC |
DOCETAXEL ANHYDROUS |
TAXOTERE® |
pubchem.compound:148124 |
drugbank:01248 |
chemidplus:114977-28-5 |
chembl:CHEMBL92 |
rxcui:1299922 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antineoplastic agent |
Drug Categories | taxane derivatives |
Drug Categories | cyclodecanes |
Year of Approval | 1996 |
Drug Class | antineoplastic agents |
Pharmaceutical Developer | BIND Biosciences |
Source Reported Drug Name(s) | BIND-014/PSMA-targeted docetaxel nanoparticle |
Drug Class | Folate Inhibitor |
Drug Categories | agents causing muscle toxicity |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a5 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | hepatotoxic agents |
Drug Categories | microtubule inhibition |
Drug Categories | microtubule inhibitors |
Drug Categories | oatp1b3 substrates |
Drug Categories | p-glycoprotein substrates |
Drug Categories | p-glycoprotein substrates with narrow therapeutic index |
n/a |
n/a |
inhibitor (inhibitory) |
Reported Cancer Type | Prostate |
n/a |
n/a |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | True |
DOCETAXEL | DrugBank Drug Name |
114977-28-5 | CAS Number |
Act Docetaxel 40 mg/ml | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
Docetaxel | Drug Trade Name |
Docetaxel | Drug Development Name |
Drug Class | Folate Inhibitor |
Source Reported Drug Name(s) | BIND-014/PSMA-targeted docetaxel nanoparticle |
Pharmaceutical Developer | BIND Biosciences |
DOCETAXEL | Primary Drug Name |
Drug Class | antineoplastic agents |
Year of Approval | 1996 |
Drug Indications | antineoplastic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
C1526 | NCI drug code |
D0O5WP | TTD Drug ID |
DOCETAXEL | GuideToPharmacology Ligand Name |